A few days ago, Ningbo Aocheng Biotechnology Co., Ltd. declared "Pre-eclampsia and other high-risk diseases diagnostic reagents and instrument research and development project for pregnant women", which has been successfully selected as a major project of "Technology Innovation 2025" in Ningbo City. Public list of project approval plans in the field.
It is understood that pre-eclampsia in pregnant women is currently an important factor leading to maternal death and premature birth of babies. There is still a big gap between prenatal screening in foreign countries and domestic ones. Due to the high price of reagents and instruments, they are very restricted in China. The research and development of high-quality and cheap domestically-made maternal preeclampsia and other high-risk basic examination instruments and reagents is a research and development project with a strong application background and major social and economic benefits.
In accordance with relevant regulations, scientific research projects included in Ningbo’s "Science and Technology Innovation 2025" major special project approval plan will be supported by special funds to accelerate the transformation of scientific research results. At the same time, the selection of scientific research projects has a strong leading effect in the field of regional scientific and technological research and development, which is conducive to accelerating the accumulation of various innovative elements and resources and building an ecosystem that is conducive to scientific and technological innovation.